“…Importantly, modification of cell culture parameters has previously been shown to significantly reshape EV intraluminal cargo composition, [ 213–238 ] augment EV production (e.g., number of EVs produced per cell), [ 213,216,219,220,229,232,237,239–247 ] and increase EV potency in a diverse array of applications including neurological disorders and injuries, wound healing, cartilage repair, kidney disease, ischemia/reperfusion (I/R) injury, myocardial infarction, and sepsis. [ 53,146,215,220,222,224,229,230,232,240,241,243,247–252 ] These changes can be produced through the adjustment of numerous upstream variables including cell seeding density, [ 240 ] media composition (i.e., serum‐free media), [ 213,228,231 ] collection frequency of EVs, [ 240 ] architecture of the culture vessel (i.e., 2D vs 3D; 2D vs 3D), [ 220,222,227,229,230,239,242,243,247,248,250,253,254 ] fluid shear stress (i.e., static vs dynamic flow), [ 250,255 ] mechanical stimulation (e.g., cyclic stretch), [ 256–258 ] exposure to hypoxia, [ 143,217,219,224,228,231,232,241,245,246,251,259–265 ] heat, [ 266 ] oxidative stress, [ 225,266 ] electrical stimulation, [ …”